Your browser doesn't support javascript.
loading
Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization.
Dugershaw-Kurzer, Battuja; Bossart, Jonas; Buljan, Marija; Hannig, Yvette; Zehnder, Sarah; Gupta, Govind; Kissling, Vera M; Nowak-Sliwinska, Patrycja; van Beijnum, Judy R; Griffioen, Arjan W; Masjosthusmann, Stefan; Zühr, Etta; Fritsche, Ellen; Hornung, René; Rduch, Thomas; Buerki-Thurnherr, Tina.
Affiliation
  • Dugershaw-Kurzer B; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Bossart J; Department of Health Sciences and Technology, ETH Zurich, Zurich, 8093, Switzerland.
  • Buljan M; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Hannig Y; Department of Health Sciences and Technology, ETH Zurich, Zurich, 8093, Switzerland.
  • Zehnder S; SIB, Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland.
  • Gupta G; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Kissling VM; SIB, Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland.
  • Nowak-Sliwinska P; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • van Beijnum JR; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Griffioen AW; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Masjosthusmann S; Laboratory for Particles-Biology Interactions, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
  • Zühr E; Institute of Pharmaceutical Sciences of Western Switzerland, Geneva, 1211, Switzerland.
  • Fritsche E; School of Pharmaceutical Sciences, University of Geneva, Geneva, 1205, Switzerland.
  • Hornung R; Angiogenesis Laboratory, Department of Medical Oncology, UMC loacation Vrije Universiteit Amsterdam, Amsterdam, 1081, The Netherlands.
  • Rduch T; Angiogenesis Laboratory, Department of Medical Oncology, UMC loacation Vrije Universiteit Amsterdam, Amsterdam, 1081, The Netherlands.
  • Buerki-Thurnherr T; IUF-Leibniz Research Institute for Environmental Medicine, 40225, Duesseldorf, Germany.
Adv Sci (Weinh) ; : e2401060, 2024 May 20.
Article in En | MEDLINE | ID: mdl-38767187
ABSTRACT
Exposure to nanoparticles (NPs) in pregnancy is increasingly linked to adverse effects on embryo-fetal development and health later in life. However, the developmental toxicity mechanisms of NPs are largely unknown, in particular potential effects on the placental secretome, which orchestrates many developmental processes pivotal for pregnancy success. This study demonstrates extensive material- and pregnancy stage-specific deregulation of placental signaling from a single exposure of human placental explants to physiologically relevant concentrations of engineered (silica (SiO2) and titanium dioxide (TiO2) NPs) and environmental NPs (diesel exhaust particles, DEPs). This includes a multitude of secreted inflammatory, vascular, and endocrine placental factors as well as extracellular vesicle (EV)-associated proteins. Moreover, conditioned media (CM) from NP-exposed explants induce pronounced anti-angiogenic and anti-vasculogenic effects, while early neurodevelopmental processes are only marginally affected. These findings underscore the potential of metal oxide NPs and DEPs for widespread interference with the placental secretome and identify vascular morphogenesis as a sensitive outcome for the indirect developmental toxicity of different NPs. Overall, this work has profound implications for the future safety assessment of NPs for industrial, commercial, or medical applications in pregnancy, which should consider placenta-mediated toxicity by holistic secretomics approaches to ensure the development of safe nanotechnologies.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Sci (Weinh) Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Sci (Weinh) Year: 2024 Document type: Article